MYDULO

This brand name is authorized in Brazil

Active ingredients

The drug MYDULO contains one active pharmaceutical ingredient (API):

1 Duloxetine
UNII 9044SC542W - DULOXETINE HYDROCHLORIDE

Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors.

Read about Duloxetine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AX21 Duloxetine N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 526121010132607, 526121010132707, 526121010132807, 526121010132907, 526121010133007, 526121010133107, 526121010133207, 526121010133307, 526121010133407, 526121010133507, 526121010133607, 526121010133707

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.